发明名称 1,2,4-OXADIAZOLE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
摘要 Disclosed is a compound of formula (I) e.g. 3-[7-(5-{ 3-chloro-4-[(1-methylethyl)oxy]phenyl} -1,2,4-oxadiazol-3-yl)-2,3,4,5-tetrahydro-1H-2-benzazepin-1-yl]propanamide or a pharmaceutically acceptable salt thereof wherein for use in the treatment of multiple sclerosis, autoimmune diseases, chronic inflammatory disorders, asthma, inflammatory neuropathies, arthritis, transplantation, Crohn's disease, ulcerative colitis, lupus erythematosis, psoriasis, ischemia-reperfusion injury, solid tumours, and tumour metastasis, diseases associated with angiogenesis, vascular diseases, pain conditions, acute viral diseases, inflammatory bowel conditions, insulin and noninsulin dependant diabetes.
申请公布号 NZ585995(A) 申请公布日期 2012.12.21
申请号 NZ20080585995 申请日期 2008.12.19
申请人 GLAXO GROUP LIMITED 发明人 HEER, JAG, PAUL;HEIGHTMAN, THOMAS, DANIEL;HURST, DAVID, NIGEL;JOHNSON, CHRISTOPHER, NORBERT;SKIDMORE, JOHN;WALL, IAN, DAVID
分类号 A61K31/553;A61K31/4245;A61K31/55;A61P37/00;C07D223/16;C07D267/14;C07D271/06;C07D413/04;C07D413/14 主分类号 A61K31/553
代理机构 代理人
主权项
地址